| NCT06595706 | Evaluating the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 in Healthy Adult Participants | COMPLETED | PHASE1 | 2024-09-28 | 2025-01-24 | 2025-01-24 |
| NCT06505239 | Assessing the Safety and Efficacy of FSD-F2R6-A-CP in Volunteers in an Induced State of Alcohol Intoxication | COMPLETED | NA | 2024-07-12 | 2024-11-07 | 2024-11-07 |
| NCT05821387 | Evaluating the Safety, Tolerability, Pharmacokinetics, and Effect of Food of Lucid-21-302 in Healthy Volunteers | COMPLETED | PHASE1 | 2023-03-22 | 2023-07-29 | 2023-07-29 |
| NCT05652907 | Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD) | TERMINATED | PHASE2 | 2023-01-19 | 2023-05-24 | 2023-05-24 |
| NCT04619706 | Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19 | TERMINATED | PHASE2 | 2020-12-14 | 2021-08-24 | 2021-08-24 |